Evidence that 13-M, a unique small molecule disruptor of adrenergic SERCA2 activity reduces infarct size and preserves cardiac function Oslo, Norway – 29 August 2023 - Serca Pharmaceuticals, a ...
As asthma progresses, the airways are changed or remodeled and become more muscular and reactive to allergens. Critical to this process is a cellular pump in the muscles called SERCA2, Proceedings of ...
Evidence that 13-M, a unique small molecule disruptor of adrenergic SERCA2 activity reduces infarct size and preserves cardiac function The findings presented suggest that specifically blocking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback